All data are based on the daily closing price as of August 1, 2025
c
Celltrion Pharm
068760.KQ
36.77 USD
-1.85
-4.79%
Overview
Last close
36.77 usd
Market cap
1.60B usd
52 week high
83.01 usd
52 week low
30.18 usd
Target price
96.74 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
8.2495
Price/Book Value
5.8063
Enterprise Value
1.71B usd
EV/Revenue
4.8812
EV/EBITDA
37.1212
Key financials
Revenue TTM
195.42M usd
Gross Profit TTM
57.50M usd
EBITDA TTM
30.44M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
458.65M usd
Net debt
N/A usd
About
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.